Suppression of LPS-induced transcription and cytokine secretion by the dietary isothiocyanate sulforaphane

Molecular Nutrition and Food Research

Volumn 58, Issue 12, 2014, Pages 2286-2296

  Folkard, Danielle L ^a   Melchini, Antonietta ^a   Traka, Maria H ^a   Al Bakheit, Ala'a ^a   Saha, Shikha ^a   Mulholland, Francis ^a   Watson, Andrew ^a   Mithen, Richard F ^a  

^a INSTITUTE OF FOOD RESEARCH   (United Kingdom)

Author keywords

Cruciferous vegetables; Inflammation; LPS; Sulforaphane; Toll like receptor 4

Indexed keywords

CYTOKINE; ISOTHIOCYANIC ACID; ISOTHIOCYANIC ACID DERIVATIVE; LIPOPOLYSACCHARIDE; SULFORAFAN; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4;

ANTAGONISTS AND INHIBITORS; BRASSICA; CELL LINE; CHEMISTRY; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; HUMAN; INFLAMMATION; LIQUID CHROMATOGRAPHY; METABOLISM; MONOCYTE; MONONUCLEAR CELL; SECRETION (PROCESS); TANDEM MASS SPECTROMETRY;

BRASSICA; CELL LINE; CHROMATOGRAPHY, LIQUID; CYTOKINES; HUMANS; INFLAMMATION; ISOTHIOCYANATES; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MONOCYTES; TANDEM MASS SPECTROMETRY; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION, GENETIC;

EID: 84912102513     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400550     Document Type: Article

References (42)

1. Juge, N., Mithen, R. F., Traka, M., Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell. Mol. Life Sci. 2007, 64, 1105-1127.
2. Navarro, S. L., Li, F., Lampe, J. W., Mechanisms of action of isothiocyanates in cancer chemoprevention: an update. Food Funct. 2011, 2, 579-587.
3. Traka, M., Mithen, R., Glucosinolates, isothiocyanates and human health. Phytochem. Rev. 2009, 8, 269-282.
4. Jiang, Y., Wu, S. H., Shu, X. O., Xiang, Y. B. et al., Cruciferous vegetable intake is inversely correlated with circulating levels of proinflammatory markers in women. J. Acad. Nutr. Diet. 2014, 114, 700-708, e702.
5. Zhang, X., Shu, X. O., Xiang, Y. B., Yang, G. et al., Cruciferous vegetable consumption is associated with a reduced risk of total and cardiovascular disease mortality. Am. J. Clin. Nutr. 2011, 94, 240-246.
6. Navarro, S. L., Schwarz, Y., Song, X., Wang, C. Y. et al., Cruciferous vegetables had variable effects on biomarkers of systemic inflammation in a randomized controlled trial in healthy young adults. J. Nutr. 2014 [Epub ahead of print].
7. Dinkova-Kostova, A. T., Kostov, R. V., Glucosinolates and isothiocyanates in health and disease. Trends Mol. Med. 2012, 18, 337-347.
8. Zhao, X. D., Zhou, Y. T., Lu, X. J., Sulforaphane enhances the activity of the Nrf2-ARE pathway and attenuates inflammation in OxyHb-induced rat vascular smooth muscle cells. Inflamm. Res. 2013, 62, 857-863.
9. Kensler, T. W., Egner, P. A., Agyeman, A. S., Visvanathan, K. et al., Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. Top Curr. Chem. 2013, 329, 163-177.
10. Chen, X., Liu, J., Chen, S. Y., Sulforaphane protects against ethanol-induced oxidative stress and apoptosis in neural crest cells by the induction of Nrf2-mediated antioxidant response. Br. J. Pharmacol. 2013, 169, 437-448.
11. Youn, H. S., Kim, Y. S., Park, Z. Y., Kim, S. Y. et al., Sulforaphane suppresses oligomerization of TLR4 in a thiol-dependent manner. J. Immunol. 2010, 184, 411-419.
12. Brandenburg, L. O., Kipp, M., Lucius, R., Pufe, T., Wruck, C. J., Sulforaphane suppresses LPS-induced inflammation in primary rat microglia. Inflamm. Res. 2010, 59, 443-450.
13. Yehuda, H., Soroka, Y., Zlotkin-Frusic, M., Gilhar, A. et al., Isothiocyanates inhibit psoriasis-related proinflammatory factors in human skin. Inflamm. Res. 2012, 61, 735-742.
14. Lin, W., Wu, R. T., Wu, T., Khor, T. O. et al., Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem. Pharmacol. 2008, 76, 967-973.
15. Wierinckx, A., Breve, J., Mercier, D., Schultzberg, M. et al., Detoxication enzyme inducers modify cytokine production in rat mixed glial cells. J. Neuroimmunol. 2005, 166, 132-143.
16. Heiss, E., Herhaus, C., Klimo, K., Bartsch, H., Gerhauser, C., Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J. Biol. Chem. 2001, 276, 32008-32015.
17. Drexler, S. K., Foxwell, B. M., The role of toll-like receptors in chronic inflammation. Int. J. Biochem. Cell Biol. 2010, 42, 506-518.
18. Takeuchi, O., Akira, S., Pattern recognition receptors and inflammation. Cell 2010, 140, 805-820.
19. Creely, S. J., McTernan, P. G., Kusminski, C. M., Fisher, M. et al., Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2007, 292, E740-E747.
20. Al-Attas, O. S., Al-Daghri, N. M., Al-Rubeaan, K., da Silva, N. F. et al., Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovasc. Diabetol. 2009, 8, 20.
21. Wiedermann, C. J., Kiechl, S., Dunzendorfer, S., Schratzberger, P. et al., Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J. Am. Coll. Cardiol. 1999, 34, 1975-1981.
22. Gandoura, S., Weiss, E., Rautou, P. E., Fasseu, M. et al., Gene- and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosis. J. Hepatol. 2013, 58, 936-948.
23. Smiljanovic, B., Grun, J. R., Steinbrich-Zollner, M., Stuhlmuller, B. et al., Defining TNF-alpha- and LPS-induced gene signatures in monocytes to unravel the complexity of peripheral blood transcriptomes in health and disease. J. Mol. Med. 2010, 88, 1065-1079.
24. Magder, S., Neculcea, J., Neculcea, V., Sladek, R., Lipopolysaccharide and TNF-alpha produce very similar changes in gene expression in human endothelial cells. J. Vasc. Res. 2006, 43, 447-461.
25. Reynier, F., de Vos, A. F., Hoogerwerf, J. J., Bresser, P. et al., Gene expression profiles in alveolar macrophages induced by lipopolysaccharide in humans. Mol. Med. 2012, 18, 1303-1311.
26. Schmelzer, C., Doring, F., Identification of LPS-inducible genes downregulated by ubiquinone in human THP-1 monocytes. Biofactors 2010, 36, 222-228.
27. Huang, H., Chang, E. J., Lee, Y., Kim, J. S. et al., A genome-wide microarray analysis reveals anti-inflammatory target genes of paeonol in macrophages. Inflamm. Res. 2008, 57, 189-198.
28. Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B. et al., Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5, R80.
29. Bengtsson, H., Simpson, K., Bullard, J., Hansen, K., aroma.affymetrix: a generic framework in R for analyzing small to very large Affymetrix data sets in bounded memory. Tech Report #745 2008, Department of Statistics, University of California, Berkeley.
30. Smyth, G. K., Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3, Article3.
31. Huang da, W., Sherman, B. T., Lempicki, R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4, 44-57.
32. Zhu, J., Ghosh, A., Coyle, E. M., Lee, J. et al., Differential effects of phenethyl isothiocyanate and D, L-sulforaphane on TLR3 signaling. J. Immunol. 2013, 190, 4400-4407.
33. Gasper, A. V., Al-janobi, A., Smith, J. A., Bacon, J. R. et al., Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli. Am. J. Clin. Nutr. 2005, 82, 1283-1291.
34. Koo, J. E., Park, Z. Y., Kim, N. D., Lee, J. Y., Sulforaphane inhibits the engagement of LPS with TLR4/MD2 complex by preferential binding to Cys133 in MD2. Biochem. Biophys. Res. Commun. 2013, 434, 600-605.
35. Park, B. S., Song, D. H., Kim, H. M., Choi, B. S. et al., The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 2009, 458, 1191-1195.
36. Hong, F., Freeman, M. L., Liebler, D. C., Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Chem. Res. Toxicol. 2005, 18, 1917-1926.
37. Hu, C., Eggler, A. L., Mesecar, A. D., van Breemen, R. B., Modification of keap1 cysteine residues by sulforaphane. Chem. Res. Toxicol. 2011, 24, 515-521.
38. Melchini, A., Needs, P. W., Mithen, R. F., Traka, M. H., Enhanced in vitro biological activity of synthetic 2-(2-pyridyl) ethyl isothiocyanate compared to natural 4-(methylsulfinyl) butyl isothiocyanate. J. Med. Chem. 2012, 55, 9682-9692.
39. Mi, L., Hood, B. L., Stewart, N. A., Xiao, Z. et al., Identification of potential protein targets of isothiocyanates by proteomics. Chem. Res. Toxicol. 2011, 24, 1735-1743.
40. Conaway, C. C., Wang, C. X., Pittman, B., Yang, Y. M. et al., Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res. 2005, 65, 8548-8557.
41. Zhang, Y. S., Callaway, E. C., High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. Biochem. J. 2002, 364, 301-307.
42. Zhang, Y. S., Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates. Carcinogenesis 2001, 22, 425-431.